Recent headlines from tech industry giants have spawned an interesting debate about the use of artificial intelligence (AI) in overall society and in healthcare. In our column in the May issue of MPO Magazine, we compiled eight arguments that support AI utilization in healthcare.

MedTech M&A, an industry bank failure, and everything else in-between in our April 2023 column in Today’s Medical Development Magazine.

As the divestitures in Healthcare Fortune 500 companies are making headlines, our team takes the time to discuss the positive impacts they have on MedTech innovation.

In our March 2023 column in Medical Product Outsourcing Magazine we discuss common mistakes MedTech sellers should avoid in order to maximize their M&A value.

The sector cannot totally turn its back on China—it’s too important of a market to overlook. Learn why in our column in Medical Product Outsourcing Magazine.

M&A conference or a CDMO/CMO event? Yes! Read our March column from Today’s Medical Developments Magazine.

In their first column of 2023 in Today’s Medical Developments Magazine, CEO Florence Joffroy-Black and Co-Founder/Managing Director Dave Sheppard share some of the key observations from the 2023 JPM Healthcare Conference.

Support those affected by the February 6th Earthquake in Turkey and Syria.

Co-Founder/Managing Director Dave Sheppard is one of several members of the MPO editorial advisory board sharing their thoughts on the headlines of 2022 and what’s coming in 2023 for MPO Magazine.

CEO & President Florence Joffroy-Black contributes her thoughts in Orthopedic Design & Technology Magazine’s Orthopedic M&A 2022 Year in Review.

Will MedTech M&A in 2023 remain a sellers market? Currently, compared to past years, 2022 investments are at historically average levels.

Our healthcare industry is in the midst of a digital transformation. In MedTech business terms, the impacts of Digital Health Tech are still sometimes ambiguous due to a combination of misalignment on both terminology and various stages of technology adoption. In this article we highlight some of segments within Digital Health Tech for our TMD community to reference as we go forward.

As M&A advisors in MedTech, we’re often asked to share the recipe for negotiating an exit deal with a larger strategic industry player. There are many ingredients in this recipe, but only about a half-dozen are key to sealing an agreement with a larger OEM. This column details some of the most important points to consider in developing an early-stage company.